Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 11.6% – Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN) shares rose 11.6% on Monday . The stock traded as high as $31.57 and last traded at $32.2460. Approximately 10,026 shares were traded during mid-day trading, a decline of 79% from the average daily volume of 48,395 shares. The stock had previously closed at $28.90.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, April 1st. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

Anbio Biotechnology Stock Performance

The firm’s 50-day moving average price is $25.19.

Anbio Biotechnology (NASDAQ:NNNN) last issued its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 earnings per share for the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.